RKT.L vs. JNJ
RKT.L (Reckitt Benckiser Group plc) and JNJ (Johnson & Johnson) are both stocks. RKT.L operates in Household & Personal Products (Consumer Defensive), while JNJ operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, RKT.L returned -1.40%/yr vs 10.83%/yr for JNJ. At a 0.21 correlation, their price movements are largely independent.
Performance
RKT.L vs. JNJ - Performance Comparison
Loading charts...
Different Trading Currencies
RKT.L is traded in GBp, while JNJ is traded in USD. To make them comparable, the JNJ values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, RKT.L achieves a -25.78% return, which is significantly lower than JNJ's 14.87% return. Over the past 10 years, RKT.L has underperformed JNJ with an annualized return of -1.40%, while JNJ has yielded a comparatively higher 10.83% annualized return.
RKT.L
- 1D
- -0.29%
- 1M
- -2.89%
- YTD
- -25.78%
- 6M
- -24.52%
- 1Y
- -11.49%
- 3Y*
- -6.65%
- 5Y*
- -4.27%
- 10Y*
- -1.40%
JNJ
- 1D
- 0.00%
- 1M
- 8.10%
- YTD
- 14.87%
- 6M
- 16.57%
- 1Y
- 56.05%
- 3Y*
- 14.39%
- 5Y*
- 11.35%
- 10Y*
- 10.83%
RKT.L vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RKT.L Reckitt Benckiser Group plc | -25.78% | 29.18% | -6.74% | -2.96% | -6.86% | -0.34% | 9.42% | 4.81% | -10.86% | 2.60% |
JNJ Johnson & Johnson | 14.53% | 36.97% | -3.15% | -13.15% | 18.58% | 12.49% | 7.57% | 11.80% | 0.49% | 13.67% |
Correlation
The correlation between RKT.L and JNJ is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2007 | 0.21 |
Fundamentals
RKT.L:
£29.59B
JNJ:
$567.68B
RKT.L:
£6.17
JNJ:
$8.65
RKT.L:
7.35
JNJ:
26.85
RKT.L:
0.15
JNJ:
0.89
RKT.L:
1.22
JNJ:
5.86
RKT.L:
3.82
JNJ:
6.99
RKT.L:
£24.88B
JNJ:
$96.36B
RKT.L:
£15.10B
JNJ:
$66.60B
RKT.L:
£6.67B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RKT.L vs. JNJ — Risk / Return Rank
RKT.L
JNJ
RKT.L vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Reckitt Benckiser Group plc (RKT.L) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RKT.L | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.77 | ||
| Sortino ratioReturn per unit of downside risk | -5.34 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 1.56 | -0.64 |
| Calmar ratioReturn relative to maximum drawdown | -0.38 | 4.53 | -4.91 |
| Martin ratioReturn relative to average drawdown | -0.95 | 14.39 | -15.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RKT.L | JNJ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.53 | 3.25 | -3.77 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | 0.64 | -0.83 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.06 | 0.55 | -0.61 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.68 | -0.38 |
Drawdowns
RKT.L vs. JNJ - Drawdown Comparison
The maximum RKT.L drawdown since its inception was -42.08%, which is greater than JNJ's maximum drawdown of -23.28%. Use the drawdown chart below to compare losses from any high point for RKT.L and JNJ.
Loading charts...
Drawdown Indicators
| RKT.L | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.08% | -23.28% | -18.80% |
Max Drawdown (1Y)Largest decline over 1 year | -30.10% | -12.44% | -17.66% |
Max Drawdown (3Y)Largest decline over 3 years | -30.10% | -16.22% | -13.88% |
Max Drawdown (5Y)Largest decline over 5 years | -35.84% | -23.28% | -12.56% |
Max Drawdown (10Y)Largest decline over 10 years | -42.08% | -23.28% | -18.80% |
Current DrawdownCurrent decline from peak | -33.20% | -5.35% | -27.85% |
Average DrawdownAverage peak-to-trough decline | -11.71% | -6.93% | -4.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.02% | 3.91% | +8.11% |
Volatility
RKT.L vs. JNJ - Volatility Comparison
Reckitt Benckiser Group plc (RKT.L) has a higher volatility of 7.09% compared to Johnson & Johnson (JNJ) at 6.24%. This indicates that RKT.L's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RKT.L | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.09% | 6.24% | +0.85% |
Volatility (6M)Calculated over the trailing 6-month period | 16.98% | 13.14% | +3.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.85% | 17.39% | +4.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.51% | 17.71% | +4.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.37% | 19.95% | +2.42% |
Dividends
RKT.L vs. JNJ - Dividend Comparison
RKT.L's dividend yield for the trailing twelve months is around 10.15%, more than JNJ's 2.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.26% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
RKT.L Reckitt Benckiser Group plc | 10.15% | 3.30% | 3.90% | 3.31% | 2.91% | 2.64% | 2.56% | 2.71% | 2.69% | 2.24% | 2.05% | 1.98% |
Financials
RKT.L vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Reckitt Benckiser Group plc and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RKT.L vs. JNJ - Profitability Comparison
RKT.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Reckitt Benckiser Group plc reported a gross profit of 4.37B and revenue of 7.22B. Therefore, the gross margin over that period was 60.6%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
RKT.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Reckitt Benckiser Group plc reported an operating income of 2.72B and revenue of 7.22B, resulting in an operating margin of 37.6%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
RKT.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Reckitt Benckiser Group plc reported a net income of 2.22B and revenue of 7.22B, resulting in a net margin of 30.8%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
RKT.L and JNJ have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for RKT.L and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer